Harvard Bioscience, Inc. Share Price
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.120 USD | +3.38% |
|
+1.32% | -8.49% |
| 05-12 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-12 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
| Market Cap | 26.7M 23.28M 21.72M 19.97M 37.49M 2.55B 38.38M 258M 101M 1.27B 100M 98.07M 4.36B | P/E 2026 * |
-3.12x | P/E 2027 * | -13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 26.7M 23.28M 21.72M 19.97M 37.49M 2.55B 38.38M 258M 101M 1.27B 100M 98.07M 4.36B | EV / Sales 2026 * |
0.3x | EV / Sales 2027 * | 0.28x |
| Free-Float |
90.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harvard Bioscience, Inc.
| 1 day | +3.38% | ||
| 1 week | +1.32% | ||
| Current month | -0.49% | ||
| 1 month | +1.32% | ||
| 3 months | -5.12% | ||
| 6 months | +6.88% | ||
| Current year | -8.49% |
| 1 week | 5.91 |  | 6.24 |
| 1 month | 5.9 | | 6.72 |
| Current year | 4 | | 7.5 |
| 1 year | 3.76 | | 9.4 |
| 3 years | 2.81 | | 55.6 |
| 5 years | 2.81 | | 87.5 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 27/07/2025 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 11/05/2025 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 23/10/2017 |
John Duke
BRD | Director/Board Member | 55 | 01/06/2025 |
Robert Gagnon
BRD | Director/Board Member | 52 | 15/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06/26 | Free | Director | 16,556 | 0.3671% | ||
| 09/06/26 | Free | Director | 16,556 | 0.3671% | ||
| 09/06/26 | Free | Director | 16,556 | 0.3671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.38% | +1.32% | +15.65% | -87.18% | 26.97M | |
| +0.01% | +10.12% | +18.87% | +2.60% | 214B | |
| -1.29% | +9.76% | -3.18% | -24.45% | 140B | |
| -2.40% | +0.87% | -28.52% | +8.14% | 128B | |
| -0.04% | +6.60% | -56.50% | -10.93% | 68.46B | |
| +2.49% | +1.43% | +9.26% | +2.41% | 48.18B | |
| +4.51% | +8.78% | -21.58% | -28.66% | 45.56B | |
| -0.17% | +5.60% | +17.37% | +11.31% | 39.69B | |
| -1.15% | +3.25% | +25.51% | +32.79% | 37.69B | |
| +2.55% | +9.44% | -21.65% | -3.98% | 30.14B | |
| Average | +1.29% | +3.87% | -4.48% | -9.80% | 75.17B | |
| Weighted average by Cap. | +0.83% | +5.29% | -4.60% | -2.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 88.6M 77.26M 72.07M 66.28M 124M 8.47B 127M 855M 334M 4.2B 333M 325M 14.48B | 94.2M 82.14M 76.63M 70.47M 132M 9.01B 135M 909M 355M 4.46B 354M 346M 15.39B |
| Net income | -9.05M -7.89M -7.36M -6.77M -12.71M -866M -13.01M -87.29M -34.12M -429M -33.98M -33.24M -1.48B | -2.05M -1.79M -1.67M -1.53M -2.88M -196M -2.95M -19.77M -7.73M -97.17M -7.7M -7.53M -335M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | US$6.120 | +3.38% | 5,103 |
| 28/07/26 | US$5.920 | -1.17% | 8,997 |
| 27/07/26 | US$5.990 | -0.17% | 7,883 |
| 24/07/26 | US$6.000 | -3.07% | 6,032 |
| 23/07/26 | US$6.190 | +0.98% | 5,421 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
